BPC 157 does inhibit MAO-inhibition, modulates serotonergic and dopaminergic systems, beneficially affects various behavioral disturbances that otherwise appeared due to specifically (over)stimulated/damaged neurotransmitters systems
This article covers the pharmacokinetic differences between routes, the tissue-level mechanisms that explain absorption variability, and exactly when IM might still be the correct choice despite SubQ's advantages
Benefits Increased energy levels and reduced fatigue Enhanced metabolism, assisting with weight management Improved mood and reduction in symptoms of depression Boosted cognitive function, including memory and concentration Strengthened immune system Healthier skin, hair, and nails Decreased risk of heart disease by lowering homocysteine levels Improved sleep patterns Increased red blood cell production, preventing anemia Enhanced nerve health and neurological function FAQ's Who is a good candidate
The positive votes are a rebuke to the agencys career scientists who urged maintaining restrictions over the lack of data and safety concerns
Some may experience a subtle recurrence of symptoms when they miss or postpone an injection or when an intercurrent disease mandates the temporary increase of injection frequency